Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
Patents for C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376)
05/2003
05/21/2003CN1109034C Composition of gambogic acid compounds with anticancer activity and its preparing process
05/21/2003CN1109028C Microwave extraction method of ginkgolic flavone and bilobalide-like substances
05/20/2003US6566509 Compound for use as bactericide
05/20/2003US6566425 Polymeric articles comprising novel bismethine benzodifuranone derivative colorants
05/20/2003US6566393 Etoposide analogs and methods of use thereof
05/20/2003CA2132429C Alkylthio alkyl avermectins are active antiparasitic agents
05/15/2003WO2003039454A2 Beta-secretase inhibitors and methods of use
05/15/2003US20030092918 Oxygen-containing heterocyclic fused naphthopyrans
05/15/2003CA2464736A1 Beta-secretase inhibitors and methods of use
05/14/2003EP1309598A1 Fluorescent compounds
05/14/2003EP1309588A1 Heterocyclylalkyl azole derivatives and use thereof as pesticidal agents
05/14/2003EP1309572A1 Silent mark for oil product and detection method thereto
05/14/2003EP1309325A1 Anticonvulsant derivatives useful for the treatment of depression
05/14/2003EP1226145B1 Naphthopyrans with a heterocycle in the 5,6-position, preparation, and compositions and matrices containing them
05/14/2003EP1140888B1 Optical molecular sensors for cytochrome p450 activity
05/14/2003CN1418207A Agents correcting gene expression regulatory error
05/14/2003CN1108373C Isolated biolgical synthesis of elliptone
05/14/2003CN1108303C Microwave extracting method of artemisine
05/13/2003CA2080402C Avermectin compounds with a 6,5-spiroketal ring system and a 23-acyl substituent
05/08/2003WO2003037316A1 Peroxisome proliferator activated receptor ligands and process for producing the same
05/08/2003WO2002094836A3 Methods for preparation and use of psorospermin analogs
05/08/2003WO2001083500A8 13-substituted milbemycin derivatives, their preparation and their use against insects and other pests
05/08/2003US20030088113 From compounds such as 1-(benzyloxy)-6-bromo-3-(1,4-dioxaspiro(4.5)dec-8-yl)-2 -oxabicyclo(2.2.2)octan -5-one
05/08/2003US20030088104 Circular dichroism
05/08/2003US20030087955 Substituted 10,11-benzo[b]fluoren-10-ones as estrogenic agents
05/08/2003US20030087888 Anticancer agents
05/08/2003CA2460134A1 Peroxisome proliferator activated receptor ligand and process for producing the same
05/07/2003EP1308448A1 Method for the preparation of chromanone
05/07/2003EP1307439A2 Synthetic salicylihalamides, apicularens and derivatives thereof
05/07/2003EP1307436A1 Process for the preparation of baccatin iii derivatives
05/07/2003EP0993462B1 Calixarene tubes as cation receptors
05/07/2003EP0792270B1 Use of 2,7,8-trimethyl-2-(beta-carboxyethyl)-6-hydroxy chroman (LLU-alpha)
05/06/2003US6559177 5, 11-Dioxa-benzo[b]fluoren-10-one and 5-oxa-11-thia-benzo[b]fluoren-10-ones as estrogenic agents
05/02/2003EP1306093A1 Nerve regeneration promoters containing semaphorin inhibitor as the active ingredient
05/02/2003EP1305348A1 Polymerization of olefinic orthoesters
05/02/2003EP1221939A4 Ortho ester lipids
05/02/2003EP1019042B1 Anti-first-pass effect compounds
05/02/2003EP0775130B1 Method for the preparation of (+/-)-calanolide a and intermediates thereof
05/01/2003WO2003035651A2 Novel artemisinine derivatives, and uses thereof for treating malaria
05/01/2003WO2003035643A1 Pyrazolyl-substituted heterocycles and their use as phytosanitary products
05/01/2003WO2003035634A1 A process for the preparation of the 14beta-hydroxy-baccatin iii-1,14-carbonate
05/01/2003WO2003035633A1 A process for the preparation of the 14beta-hydroxy-baccatin iii-1,14-carbonate
05/01/2003WO2003034825A1 Anthelmintic composition
05/01/2003WO2003014063A3 Protected 3.5-dihydroxy-2.2-dimethyl-valeroamides for the synthesis of epothilone and derivatives and method for the production and use thereof
05/01/2003WO2002081478A3 Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide hiv protease inhibitors
05/01/2003US20030083529 Process for producing vinyl ether compounds
05/01/2003US20030083407 Polymeric articles comprising novel bismethine benzodifuranone derivative colorants
05/01/2003US20030083369 Pyranocoumarin compounds as a novel pharmacophore with anti-TB activity
05/01/2003US20030083327 Inhibitors of Aurora-2 protein kinases and Glycogen synthase kinase-3 (GSK-3); cancer, diabetes, Alzheimer's disease, and schizophrenia treatment
05/01/2003US20030082830 Compound for use as diagnostic and therapeutic tools in medicine and science
05/01/2003US20030082510 Treatment for viral or bacterial infections of blood; obtain blood sample, incubate with test compound, expose to light, evaluate sample for presence active pathogen
05/01/2003CA2464403A1 Anthelmintic composition
04/2003
04/30/2003CN1414959A Process for production of 5-oxy-7-oxabicyclo-[4.1.0]hept-3-ENE-3-carboxylic acid esters
04/29/2003US6555696 Used as nucleating agents which are useful for improving the optical properties of polymeric materials; useful as gelling agents for water and organic solvents, particularly those used in the preparation of antiperspirant gel sticks
04/29/2003US6555663 Prodrugs for selective drug delivery
04/29/2003US6555560 Antidepressant azaheterocyclylmethyl derivatives of 1,4,5-trioxa-phenanthrene
04/24/2003WO2003033501A1 Himbacine analogues as thrombin receptor antagonists
04/24/2003WO2003033491A1 Medicinal composition for prevention or alleviation of side effect of antitumor and medicinal antitumor composition
04/24/2003WO2003032905A2 Preparation and use of carbohydrate-based ring structures with antimicrobial and cytostatic activity
04/24/2003WO2002060436A8 Use of fredericamycin a and its derivatives in the treatment of pin1-associated states
04/24/2003WO2002057259A3 Pyrazole compounds useful as protein kinase inhibitors
04/24/2003US20030078292 Gambogic acid, analogs and derivatives as activators of caspases and inducers of apoptosis
04/24/2003US20030078291 Novel compound having antimalarial activity
04/24/2003US20030078275 For therapy of cancer, diabetes and Alzheimer's disease
04/24/2003US20030078166 Pyrazole compounds useful as protein kinase inhibitors
04/24/2003CA2684419A1 Preparation and use of carbohydrate-based bicyclic ring structures with antimicrobial and cytostatic activity
04/24/2003CA2463628A1 Himbacine analogues as thrombin receptor antagonists
04/23/2003EP1304110A2 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
04/23/2003EP0915846B1 2- and 2,5-substituted phenylketoenols
04/23/2003CN1413181A Novel hydronaphtalene compounds prepared by phodium catalyzed ring opening reaction in presence of phosphine ligand
04/23/2003CN1106398C Block oligomers containing 1-hydrocarbyloxy-2,2,6,6-tetramethyl-4-piperidyl groups as stabilizers for organic materials
04/23/2003CN1106397C Block oligomers containing 1-hydrocarbyloxy-2,2,6,6-tetramethyl-4-piperidyl groups as stabilizers for organic materials
04/23/2003CN1106396C Blodk oligomers containing 1-hydrocarbyloxy-2,2,6,6-tetramethyl-4-piperidyl groups as stabilizers for organic materials
04/22/2003US6552071 Methods for treating cell death diseases and inflammation
04/22/2003US6552054 Chromone derivatives, process for the preparation of the same and uses thereof
04/22/2003US6552049 Antidepressant azaheterocyclylmethyl derivatives of oxaheterocycle-fused-[1,4]-benzodioxans
04/17/2003WO2002092564A3 Synthesis of cyclopentadiene derivatives
04/17/2003US20030073770 Reworkable compositions of oxirane(s) or thirane(s)-containing resin and curing agent
04/17/2003US20030073745 Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents, especially for cervical cancers and dysplasias
04/17/2003US20030073687 Alzheimer's disease; anticancer agents; antidiabetic agents
04/17/2003US20030073677 Synergistic mixtures; anticancer agents; 2-(2 -methyl-4-thiazolyl)ethenyl)-4,17-dioxabicyclo(14.1.0)heptadecane-5,9 -dione or 4-aza-17-oxabicyclo(14.1.0) heptadecane-5,9-dione or 1-aza-13-cyclohexadecene-2,6-dione or 1-oxa-13-cyclohexadecene-2,6-dione derivatives
04/16/2003EP1302470A1 Lipid-rich plaque inhibitors
04/16/2003CN1410421A Intermediate for preparing 10-deacetylation baccatin III and 10-deacetylation-14 beta hydroxy baccatin III derivatives
04/16/2003CN1105723C Spirocyclic metalloprotease inhibitors
04/16/2003CN1105722C Arteannuin derivative containing azacyclic radical and preparing process thereof
04/15/2003US6548581 Asymmetric halogen-alkyl alditol derivatives as nucleators and clarifiers for polyolefins, and polyolefin plastic compositions containing same
04/15/2003US6548537 Immunosuppression for inhibition of transplant rejection, graft versus host disease, or autoimmune disease; low toxicity
04/15/2003US6547988 Plastic additives which are useful as nucleating agents and which are especially useful for improving the optical properties of polymeric materials; also useful as gelling agents for water and organic solvents
04/11/2003CA2506646A1 Serotonin transport inhibitors
04/10/2003WO2003029237A1 Products of condensations of hydroxycoumarin derivatives with aromatic and aliphatic dialdehydes, their preparation and antiviral action thereof
04/10/2003WO2003029213A1 Spirocyclic 3-phenyl-3-substituted 4-ketolactams and 4-ketolactones
04/10/2003WO2003029195A1 Intermediates for epothilone derivative and process for producing these
04/10/2003WO2002102793A3 Quinazolinediones as antibacterial agents
04/10/2003US20030069277 Anticancer agents
04/10/2003US20030069269 Tropane analogs and methods for inhibition of monoamine
04/10/2003US20030069192 May be administered along with Rutin, a Rutin congener and/or a Rutin derivative.
04/10/2003US20030069190 Alkali and alkaline earth metal salts of topiramate
04/10/2003US20030068668 Compound for use as diagnostic tool in the determination of hydrogen ion concentration in fluids
04/10/2003CA2462414A1 Products of condensations of hydroxycoumarin derivatives with aromatic and aliphatic dialdehydes, their preparation and antiviral action thereof
04/09/2003EP1299393A2 4-phenyl substituted tetrahydroisoquinolines and therapeutic use thereof
1 ... 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 ... 174